In gastric cancer (GC), where SET overexpression at both protein and mRNA levels represents a marker of poor prognosis, SET down-regulation by shRNAs impaired GC cell proliferation, colony formation, tumorigenesis, and metastasis in vitro and in vivo [91]. This evidence concerns the gene SET and gastric cancer.